Koup RA - Search Results

1

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.

Graham BS, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Martin JE, McCluskey MM, Chakrabarti BK, Lamoreaux L, Andrews CA, Gomez PL, Mascola JR, Nabel GJ; Vaccine Research Center 004 Study Team. Graham BS, et al. Among authors: koup ra. J Infect Dis. 2006 Dec 15;194(12):1650-60. doi: 10.1086/509259. Epub 2006 Nov 8. J Infect Dis. 2006. PMID: 17109336 Free PMC article. Clinical Trial.

2

A region of the third variable loop of HIV-1 gp120 is recognized by HLA-B7-restricted CTLs from two acute seroconversion patients.

Safrit JT, Lee AY, Andrews CA, Koup RA. Safrit JT, et al. Among authors: koup ra. J Immunol. 1994 Oct 15;153(8):3822-30. J Immunol. 1994. PMID: 7523505

3

hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.

Safrit JT, Fung MS, Andrews CA, Braun DG, Sun WN, Chang TW, Koup RA. Safrit JT, et al. Among authors: koup ra. AIDS. 1993 Jan;7(1):15-21. doi: 10.1097/00002030-199301000-00002. AIDS. 1993. PMID: 7680205

4

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Koup RA, et al. J Virol. 1994 Jul;68(7):4650-5. doi: 10.1128/JVI.68.7.4650-4655.1994. J Virol. 1994. PMID: 8207839 Free PMC article.

5

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope.

Safrit JT, Andrews CA, Zhu T, Ho DD, Koup RA. Safrit JT, et al. Among authors: koup ra. J Exp Med. 1994 Feb 1;179(2):463-72. doi: 10.1084/jem.179.2.463. J Exp Med. 1994. PMID: 8294860 Free PMC article.

6

Human peripheral blood xenografts in the SCID mouse: characterization of immunologic reconstitution.

Hesselton RM, Koup RA, Cromwell MA, Graham BS, Johns M, Sullivan JL. Hesselton RM, et al. Among authors: koup ra. J Infect Dis. 1993 Sep;168(3):630-40. doi: 10.1093/infdis/168.3.630. J Infect Dis. 1993. PMID: 8354904

7

The immunopathology of HIV infection.

Andrews CA, Koup RA. Andrews CA, et al. Among authors: koup ra. J Antimicrob Chemother. 1996 May;37 Suppl B:13-25. doi: 10.1093/jac/37.suppl_b.13. J Antimicrob Chemother. 1996. PMID: 8818826 Review.

8

Optimal antigens for HIV vaccines based on CD8+ T response, protein length, and sequence variability.

Betts MR, Yusim K, Koup RA. Betts MR, et al. Among authors: koup ra. DNA Cell Biol. 2002 Sep;21(9):665-70. doi: 10.1089/104454902760330200. DNA Cell Biol. 2002. PMID: 12396609 Clinical Trial.

9

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells.

Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, Crotty LE, Casazza JP, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. Brenchley JM, et al. Among authors: koup ra. Blood. 2003 Apr 1;101(7):2711-20. doi: 10.1182/blood-2002-07-2103. Epub 2002 Nov 14. Blood. 2003. PMID: 12433688 Free article.

10

Optimized determination of T cell epitope responses.

Roederer M, Koup RA. Roederer M, et al. Among authors: koup ra. J Immunol Methods. 2003 Mar 1;274(1-2):221-8. doi: 10.1016/s0022-1759(02)00423-4. J Immunol Methods. 2003. PMID: 12609547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page